Cargando…
Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255283/ https://www.ncbi.nlm.nih.gov/pubmed/32834951 http://dx.doi.org/10.1016/j.apsb.2020.05.006 |
| _version_ | 1783539706006339584 |
|---|---|
| author | Jin, Tianru Liu, Mingyao |
| author_facet | Jin, Tianru Liu, Mingyao |
| author_sort | Jin, Tianru |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7255283 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72552832020-05-28 Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment Jin, Tianru Liu, Mingyao Acta Pharm Sin B Letter to the Editor Elsevier 2020-07 2020-05-26 /pmc/articles/PMC7255283/ /pubmed/32834951 http://dx.doi.org/10.1016/j.apsb.2020.05.006 Text en © 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Jin, Tianru Liu, Mingyao Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment |
| title | Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment |
| title_full | Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment |
| title_fullStr | Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment |
| title_full_unstemmed | Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment |
| title_short | Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment |
| title_sort | letter to the editor: comment on glp-1-based drugs and covid-19 treatment |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255283/ https://www.ncbi.nlm.nih.gov/pubmed/32834951 http://dx.doi.org/10.1016/j.apsb.2020.05.006 |
| work_keys_str_mv | AT jintianru lettertotheeditorcommentonglp1baseddrugsandcovid19treatment AT liumingyao lettertotheeditorcommentonglp1baseddrugsandcovid19treatment |